Overexpression of Notch3 is associated with ovarian cancer recurrence and chemoresistance to carboplatin (Park et al., 2010), which predicts a poor prognosis in ovarian cancer (Jung et al., 2010). This evidence concerns the gene NOTCH3 and ovarian cancer.